Patent ID: 11952364
Assignee: TYLIGAND BIOSCIENCE (SHANGHAI) LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 17:
18. The method of claim 17, wherein the diseases or disorders are tumors or cancers selected from the group consisting of sarcoma skin cancer, neuroblastoma, ovarian cancer, breast cancer, prostate cancer, pancreatic cancer, salivary gland cancer, multiple myeloma, astrocytoma and medulloblastoma, neuroglioma, melanoma, thyroid cancer, lung adenocarcinoma, large cell neuroendocrine tumors, head and neck cancer and colorectal cancer, cholangiocarcinoma, glioblastoma, glioma, secretory breast cancer, mammary secretory carcinoma, acute myeloid leukemia, congenital mesoderm nephroma, congenital fibrosarcoma, acute lymphoblastic leukemia, colon adenocarcinoma, gastrointestinal stromal tumor.